Fagron NV - Asset Resilience Ratio

Latest as of December 2025: 0.00%

Fagron NV (FAGR) has an Asset Resilience Ratio of 0.00% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read FAGR total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

€11.00K

≈ $12.86K USD Cash + Short-term Investments

Total Assets

€1.24 Billion

≈ $1.45 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how Fagron NV's Asset Resilience Ratio has changed over time. See Fagron NV shareholders equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Fagron NV's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Fagron NV market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€11.00K	0.0%
Total Liquid Assets	€11.00K	0.00%

Asset Resilience Insights

Limited Liquidity: Fagron NV maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Fagron NV Industry Peers by Asset Resilience Ratio

Compare Fagron NV's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	1.96%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Guobang Pharma Ltd SHG:605507	Drug Manufacturers - Specialty & Generic	8.47%

Annual Asset Resilience Ratio for Fagron NV (2015–2025)

The table below shows the annual Asset Resilience Ratio data for Fagron NV.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.00%	€11.00K ≈ $12.86K	€1.24 Billion ≈ $1.45 Billion	-0.08pp
2024-12-31	0.08%	€886.00K ≈ $1.04 Million	€1.08 Billion ≈ $1.27 Billion	-0.34pp
2023-12-31	0.42%	€4.27 Million ≈ $4.99 Million	€1.01 Billion ≈ $1.18 Billion	+0.38pp
2022-12-31	0.05%	€451.00K ≈ $527.27K	€971.01 Million ≈ $1.14 Billion	+0.21pp
2021-12-31	-0.16%	€-1.32 Million ≈ $-1.54 Million	€800.42 Million ≈ $935.78 Million	-0.05pp
2020-12-31	-0.11%	€-862.00K ≈ $-1.01 Million	€752.83 Million ≈ $880.13 Million	+0.14pp
2019-12-31	-0.26%	€-2.07 Million ≈ $-2.42 Million	€801.24 Million ≈ $936.73 Million	-0.45pp
2018-12-31	0.19%	€1.29 Million ≈ $1.51 Million	€682.77 Million ≈ $798.23 Million	+0.22pp
2017-12-31	-0.03%	€-163.00K ≈ $-190.56K	€594.05 Million ≈ $694.50 Million	-0.12pp
2016-12-31	0.09%	€816.00K ≈ $953.99K	€868.05 Million ≈ $1.01 Billion	+0.72pp
2015-12-31	-0.63%	€-4.32 Million ≈ $-5.05 Million	€689.38 Million ≈ $805.96 Million	--

pp = percentage points

About Fagron NV

BR:FAGR Belgium Drug Manufacturers - Specialty & Generic

Market Cap

$2.06 Billion

€1.76 Billion EUR

Market Cap Rank

#6987 Global

#36 in Belgium

Share Price

€24.00

Change (1 day)

+0.00%

52-Week Range

€19.58 - €24.40

All Time High

€24.40